Literature DB >> 18563842

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

Valerio Nobili1, Francesco Vizzutti, Umberto Arena, Juan G Abraldes, Fabio Marra, Andrea Pietrobattista, Rodolfo Fruhwirth, Matilde Marcellini, Massimo Pinzani.   

Abstract

UNLABELLED: Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in chronic liver disease patients. In this study, we assessed the value of TE for the prediction of fibrosis stage in a cohort of pediatric patients with nonalcoholic steatohepatitis. Furthermore, TE interobserver agreement was evaluated. TE was performed in 52 consecutive biopsy-proven nonalcoholic steatohepatitis patients (32 males, 20 females, age 13.6 +/- 2.44 years). The area under the receiver operating characteristic curves for the prediction of "any" (>or=1), significant (>or=2), or advanced fibrosis (>or=3) were 0.977, 0.992, and 1, respectively. Calculation of multilevel likelihood ratios showed that TE values <5, <7, and <9 kPa, suggest the presence of "any" fibrosis, significant fibrosis, and advanced fibrosis, respectively. TE values between 5 and 7 kPa predict a fibrosis stage of 1, but with some degree of uncertainty. TE values between 7 and 9 kPa predict fibrosis stages 1 or 2, but cannot discriminate between these two stages. TE values of at least 9 kPa are associated with the presence of advanced fibrosis. The intraclass correlation coefficient for absolute agreement was 0.961.
CONCLUSION: TE is an accurate and reproducible methodology to identify pediatric subjects without fibrosis or significant fibrosis, or with advanced fibrosis. In patients in which likelihood ratios are not optimal to provide a reliable indication of the disease stage, liver biopsy should be considered when clinically indicated.

Entities:  

Mesh:

Year:  2008        PMID: 18563842     DOI: 10.1002/hep.22376

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  101 in total

1.  Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection.

Authors:  Sebastian Kummer; Abdurrahman Sagir; Simone Pandey; Markus Feldkötter; Sandra Habbig; Friederike Körber; Dietrich Ney; Bernd Hoppe; Dieter Häussinger; Ertan Mayatepek; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

2.  Fatty liver disease in children: eat now pay later.

Authors:  Ruth M L De Bruyne; Emer Fitzpatrick; Anil Dhawan
Journal:  Hepatol Int       Date:  2010-01-29       Impact factor: 6.047

Review 3.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

Authors:  Stavra A Xanthakos; Daniel J Podberesky; Suraj D Serai; Lili Miles; Eileen C King; William F Balistreri; Rohit Kohli
Journal:  J Pediatr       Date:  2013-09-21       Impact factor: 4.406

5.  Learning curve of liver stiffness measurement using a new hybrid machine composed of transient elastography interfaced with ultrasound.

Authors:  Christophe Cassinotto; Marie-Ange Pierredon-Foulongne; Ali Belgour; Julien Delicque; Laure Escal; Nicolas Molinari; Sophie Anselme; Tony Jacq; Ugo Chamard-Champliaud; Bastien Nicolan; Carole Allimant; Boris Guiu
Journal:  Eur Radiol       Date:  2019-10-14       Impact factor: 5.315

Review 6.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

7.  Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions.

Authors:  An Tang; Guy Cloutier; Nikolaus M Szeverenyi; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2015-04-23       Impact factor: 3.959

8.  Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.

Authors:  Bryan Rudolph; Nicole Bjorklund; Nadia Ovchinsky; Debora Kogan-Liberman; Adriana Perez; Mark Liszewski; Terry L Levin; Michelle Ewart; Qiang Liu; Xiaonan Xue; Shankar Viswanathan; Howard D Strickler
Journal:  Contemp Clin Trials       Date:  2018-10-27       Impact factor: 2.226

Review 9.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

Authors:  Mustafa Koplay; Mesut Sivri; Hasan Erdogan; Alaaddin Nayman
Journal:  World J Hepatol       Date:  2015-04-18

Review 10.  The metabolic syndrome and nonalcoholic fatty liver disease in children.

Authors:  Shikha S Sundaram; Phil Zeitler; Kristen Nadeau
Journal:  Curr Opin Pediatr       Date:  2009-08       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.